The 3 Best Artificial Intelligence (AI) Growth Stocks to Buy on the Nasdaq Before Q1 Earnings Season

The article is bullish on Nvidia, Micron, and AMD ahead of earnings, citing strong AI infrastructure demand, severe supply constraints, and upbeat revenue/margin prospects. Nvidia is guided to 77% year-over-year Q1 revenue growth to $78 billion, with commentary suggesting results could reach closer to $80 billion. Micron is expected to post another blowout quarter on surging DRAM/NAND pricing, while AMD could benefit from GPU/CPU shortages and new MI450 demand from Meta and OpenAI.

Analysis

The market is still underestimating how much of the current AI capex wave is being translated from “spend intent” into actual silicon pull-through. The second-order winner is not just the obvious GPU leaders, but the adjacent bottlenecks: advanced packaging, HBM, substrate capacity, and test/equipment vendors. That means the near-term earnings beat/miss framework is less important than forward commentary on supply allocation and customer prepayments, because the current cycle is being constrained by manufacturing throughput rather than end-demand.

NVDA remains the cleanest expression of hyperscaler capex, but the risk/reward is more about guide quality than the headline quarter. If management signals any moderation in backlog conversion or a shift in mix toward lower-margin rack solutions, the stock can digest good numbers without re-rating. Conversely, a reaffirmation that supply remains tight into multiple quarters would pressure customers and competing accelerators, but it also raises the probability of incremental capex being redirected into the ecosystem, which supports ASML/TSM/MU over a 6-12 month horizon.

AMD is the more interesting relative-value setup because the market still prices it as a share-taker, not a capacity-constrained platform beneficiary. The bullish surprise would be in enterprise and cloud CPU tightness, which is a less crowded narrative than GPUs and could persist longer if agentic workloads increase inference demand. The key contrarian point: if AMD proves it can monetize both GPU and CPU shortages simultaneously, the multiple can expand faster than revenue, especially with product launches and customer commitments reducing execution uncertainty.

The main risk is that the cycle becomes too consensus and the stocks trade on expectations rather than fundamentals. Any sign that hyperscaler capex growth is peaking, or that supply constraints ease faster than demand, would hit the whole group simultaneously and likely compress forward multiples first, not earnings. META and NDAQ are effectively incidental here; they matter only as proxies for ad spend durability and market liquidity, not as direct AI beneficiaries in this setup.

Key Decisions for Investors

• Go long NVDA into earnings only on a pullback, using a staggered entry over the next 1-2 weeks; take profits into the print if the stock reclaims prior highs before guidance, since implied expectations are already elevated.
• Prefer long AMD vs short NVDA as a relative-value trade over the next 2-4 months; AMD has more room for multiple expansion if CPU scarcity is real, while NVDA is closer to perfection pricing.
• Add to MU on weakness for a 6-12 month horizon; the risk/reward improves if management signals long-term HBM commitments, which would reduce cyclicality and support re-rating.
• Maintain or initiate long ASML/TSM as a supply-chain leverage basket for the next 6 months; these names should benefit if AI capex remains constrained by manufacturing capacity rather than demand fatigue.
• Buy call spreads on AMD or NVDA into the next earnings window rather than outright shares if volatility is still cheap; the cleaner payoff is on guide-driven upside, with defined risk if the market fades the entire AI complex.